We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advancing Molecular Diagnostics with dPCR

Article   May 03, 2017

 
Advancing Molecular Diagnostics with dPCR

Jack Rudd

Managing Editor

 
 
 

RELATED ARTICLES

Synthetic Biology Rewrites the Rules of the Genome

Article

Synthetic biology (SB) is an umbrella term that covers a wide range of scientific applications. In this article we'll explore work aiming to synthesize genes faster than ever before, expand the genetic alphabet and turn DNA into a storage medium. To this end, we interviewed two leading figures in the field, Emily Leproust PhD, CEO of Twist Bioscience and Floyd Romesberg PhD, a Professor of Chemistry at the Scripps Institute.

READ MORE

Overcoming Challenges in Biopharma: Transformational Innovation is Key

Article

Looking at the industry growth and the complexities of biopharma development, it is no wonder that transformational developments are required to better equip laboratories and operations in biopharma.

READ MORE

Quantifying Minimal Residual Disease in Chronic Myeloid Leukemia

Article

Thanks to advances in therapeutics, chronic myeloid leukemia has been transformed from a deadly cancer into a manageable, chronic condition. However, patients have to stay on these drugs their whole lives, as there isn't a diagnostic test sensitive enough to detect traces of the disease that threaten a relapse. This article delves into the unmet need for such a test, and explains why droplet digital PCR (ddPCR) is a strong candidate that may fill this gap.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE